$CL

Clorox (CLX) offers a higher dividend yield (5.89%) than Colgate-Palmolive (CL) (2.27%), but its financial health raises concerns. Clorox's stock fell 22.44% in the past year, increasing its yield, while Colgate's rose 23.55%. Clorox's dividend payout ratio is thin, and its gross margin and cash flow have declined. Colgate shows stronger financials, with rising margins and free cash flow, and a longer dividend growth track record. Analysts prefer Colgate for its stability and growth prospects.

JPMorgan raised its price target for Colgate-Palmolive (CL) to $104 from $103. The stock has seen a 5-day change of 1.55% and a 1-year change of 19.10%. UBS also adjusted its target to $106 from $109, maintaining a buy rating.

Colgate-Palmolive (CL) declared a quarterly dividend of $0.53 per share, payable Nov. 13 to shareholders of record by Oct. 20. Investors need 472 shares, costing ~$43,240, to generate $1,000 in yearly dividends. CL has a 2.3% forward yield and a 63-year dividend growth streak, according to the company.

Colgate-Palmolive increased advertising spending by 15% in Q2 2026, reaching $777 million, about 14.5% of net sales. The company's strategy focuses on premium products and AI-tested content, but North American organic sales fell 3.0% in the quarter. CEO Noel Wallace expects continued investment in advertising. Net sales were $20.38 billion in 2025, up 1.4% from 2024.

Catalina Snacks, Molson Coors, Keurig Dr Pepper, Coca-Cola, Colgate-Palmolive, Nissin Foods, and Ocean Spray announced new executive hires to drive growth. Roles focus on digital transformation, AI integration, and supply chain optimization. Key appointments include Charlotte Mostaed at Catalina, Matthew Hook at Molson Coors, and Russ Torres at Keurig Dr Pepper.

Colgate-Palmolive (CL) is a dividend king with a 2.5% yield, 63 years of consecutive dividend increases, and strong market shares in oral care and pet nutrition. Hedge funds rank it among top dividend stocks, but its valuation is high at 21x forward earnings. The company's stability and cash flow support dividends, but investors must assess its premium pricing and future growth prospects.

BofA reduced its price target for Colgate-Palmolive (CL) to $100 from $102 but maintained a Buy rating. The analyst noted stabilizing consumption trends and improved sentiment in the consumer staples sector ahead of Q3 earnings.

Colgate-Palmolive (India) shares rose 8% after the GST Council recommended expanding input tax credit eligibility. The changes aim to reduce taxes and ease working-capital pressures. The company also benefited from a GST rate cut on oral-care products last year. Analysts estimate cost impacts from the inverted duty structure. The company reported strong revenue growth in Q1 FY27 and outlined growth strategies at an investor day.

Wells Fargo lowered its price target for Colgate-Palmolive (CL) from $95 to $90, keeping an Equalweight rating. The stock is currently trading at $84.26, down 0.32% over 5 days and 2.09% over 1 year, but up 6.63% year-to-date.

Colgate-Palmolive (CL) reaffirmed its quarterly dividend of $0.53 per share. Its share price has declined 4.7% over 30 days and 5.6% over 90 days, but is up 11.4% year-to-date and over 30% in 3 years. Analysts debate its valuation, with fair value estimates ranging from $86.48 to $128.18, highlighting differing views on its income profile and growth prospects.